CompletedNot Applicable

The Effect of The Ten-Session Dual-tDCS On Lower-Limb Performance in Sub- Acute and Chronic Stroke

Thailand34 participantsStarted 2021-01-01

Plain-language summary

The present study aims to determine the effect of the ten-session dual tDCS combine with physical therapy on gait performance, balance, and lower limbs muscle strength in patients with subacute and chronic stroke.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age range 20-75 years * First ever-ischemic lesion in the territory of middle cerebral artery or anterior cerebral artery. Diagnostic confirmation will be performed by CT scan or MRI * Sub-acute onset (1-6 months after the stroke onset) or Chronic (6 months - 5 years) * Able to walk without physical assistance at least 6 meters Exclusion Criteria: * Not cooperative or cannot understand the instruction * Clinical unstable such as vital sign unstable (systolic blood pressure (SBP) ≥ 185 mmHg or diastolic blood pressure (DBP) ≥ 110 mmHg (98) and resting heart rate averaging ≥ 100 bpm (99)) * No clear neurological antecedent history or psychiatric disorder * Moderate pain in any joint of both lower limb (Pain Scale (VAS) ≥ 4/10) * Unstable medical conditions such as being in the middle of changing medical treatment. * Condition that may increase the risk of stimulation such as epilepsy, pregnancy, unexplained headaches, intracranial metal, pacemaker (evaluating by subjective examination). * Participate in the other protocol or receive alternative treatment such as transcranial magnetic stimulation within 1 month.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from baseline gait speed at post-intervention

Timeframe: immediately post-intervention

Change from baseline gait speed at 1 week post-intervention

Timeframe: 1 week post-intervention

Change from baseline gait speed at 1 month post-intervention

Timeframe: 1 month post-intervention

Change from baseline gait speed at 2 month post-intervention

Timeframe: 2 month post-intervention

Change from baseline gait speed at 3 month post-intervention

Timeframe: 3 month post-intervention

Trial details

NCT IDNCT04687033

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More Stroke, Ischemic trials